Overview
Investment Type
Venture Capital
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 25, 2013 | A rheumatoid arthritis test and app to track disease levels could improve drug choices | About 1.5 million in the U.S. were diagnosed with rheumatoid arthritis as of 2005, according to the Centers for Disease Control and Prevention. The Vectra DA test ascertains the presence of 12 biomarkers not only to confirm a diagnosis of r... |
| Sep 12, 2012 | Fundraising: Startup developing nonsurgical treatment for urinary incontinence raises $3.9M | Solution/product: The Renessa System uses a probe guided through the urethra and radio frequency energy to treat female stress urinary incontinence in lieu of surgical treatments. The product has been cleared by the U.S. Food and Drug Admin... |
| May 19, 2009 | Satiety secures $7.5M bridge for tummy tuck shortcut | Satiety, maker of a minimally-invasive device that shrinks stomach capacity via the mouth, has landed a $7.5 million bridge loan from its existing investors — a group that includes Skyline Ventures, HLM Venture Partners, Pinnacle Ventures, ... |
| Feb 4, 2009 | SpinalMotion stacks up $500K for fake spinal discs | Artificial spinal disc producer SpinalMotion, just tacked $500,000 onto its $20 million third round of funding through a patent licensing agreement with an unnamed corporation. Based in Mountain View, Calif., the company makes both cervical... |
| Oct 29, 2008 | BioLogix bags $6M for oncology drug, names new CEO | Biopharm company BioLogix raised $6 million in first-round equity and debt financing from Essex Woodlands Health Ventures and New Science Ventures. The money will be used to continue development of its top cancer-fighting compound, but a se... |
| Nov 14, 2007 | Life sciences briefing: Wednesday, Nov. 14, 2007 | Featured companies: Advanced Bio-Surfaces, Ambit Biosciences, EnteroMedics, Molecular Vision, Skyline Ventures UPDATED: Expanded items on Skyline Ventures, Ambit, and Molecular Vision, and moved EnteroMedics to a new item here. Skyline Vent... |
| Sep 28, 2007 | Can ToleRx Escape the Autoimmunity-Drug-Development Deathtrap? | Share Share on Facebook Share on Twitter LinkedIn Email Reprints “Like does not like like that is obnoxious.” Poet Marianne Moore wasn’t thinking of autoimmune diseases when she penned this line but it memorably captures the strife behind t... |
| Jul 19, 2007 | Satiety pulls in $30M for obesity device | Satiety, a Palo Alto, Calif., device maker focused on obesity, raised $30 million in a fourth round of funding. Skyline Ventures led the round, joined by HLM Venture Partners, Pinnacle Ventures, Venrock, Three Arch Partners, Morgenthaler Ve... |
| Jun 12, 2007 | Arca Discovery raises $18M for cardiovascular drug | Arca Discovery, a Denver developer of a next-generation beta blocker for heart failure, raised $18 million in a second funding round. (The release is out, but not yet available on the Web.) The round was led by Skyline Ventures and joined b... |
Show more
Reviews 0
FAQ about Skyline Ventures
What has the press written about Skyline Ventures?
Parsers VC has collected 12 articles mentioning Skyline Ventures, among them “A rheumatoid arthritis test and app to track disease levels could improve drug choices” (Jan 25, 2013) and “Fundraising: Startup developing nonsurgical treatment for urinary incontinence raises $3.9M” (Sep 12, 2012).
Is Skyline Ventures still active?
Yes, Skyline Ventures is active; its latest activity on Parsers VC dates from Oct 29, 2018.